Mark F Maurer - Bristol-Myers Squibb

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 43 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

33 Development of a Clinical Ex Vivo Assay for the Assessment of Therapeutic CD28 Costimulatory Pathway Engagement

Jing Yang,Gary Means,Pamela Holland,Chelsea Gudgeon,Mark Maurer,Sherri Mudri,Lori Blanchfield,Stacey Dillon,Zelanna Goldberg,Stanford Peng

Journal for immunotherapy of cancerno. Suppl 2 (2021): A39-A39

引用0浏览0引用

DEVELOPMENT OF A CLINICAL EX VIVO ASSAY FOR THE ASSESSMENT OF THERAPEUTIC CD28 COSTIMULATORY PATHWAY ENGAGEMENT

Chelsea Gudgeon,Mark Maurer,Gary Means,Sherri Mudri,Lori Blanchfield,Jing Yang,Stacey Dillon,Pamela Holland,Zelanna Goldberg,Stanford Peng

JOURNAL FOR IMMUNOTHERAPY OF CANCER（2021）

引用0浏览0引用

Development of Novel Monoclonal Antibodies for the Robust Detection of CD28, CD80 and CD86 by Immunohistochemistry in Human Tumors

Gary Means,Russell Sanderson,Brian Johnson,Megan Larmore,Mark Maurer,Stanford Peng

LABORATORY INVESTIGATION（2020）

引用0浏览0引用

Abstract LB-085: ALPN-202 Combines Checkpoint Inhibition with Conditional T Cell Costimulation to Overcome T Cell Suppression by M2c Macrophages and Improve the Durability of Engineered T Cell Anti-Tumor Responses

Mark F. Maurer,Siddarth Chandrasekaran,Katherine Lewis,Sherri Mudri,Kayla Kleist,Fariha Ahmed-Qadri,Chelsea Gudgeon,Steven D. Levin,Stacey R. Dillon,Kristine M. Swiderek,Stanford L. Peng

Cancer research（2020）

引用0浏览0引用

ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor, enhances the activity of multiple standard of care modalities

Katherine Lewis,Mark Maurer,Sherri Mudri,Kayla Susmilch,Fariha Ahmed-Qadri,Chelsea Gudgeon,Steven Levin,Martin Wolfson,Stacey Dillon,Kristine Swiderek,Stanford Peng

JOURNAL FOR IMMUNOTHERAPY OF CANCER（2019）

引用1浏览0引用

ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor, utilizes multiple mechanisms to elicit potent anti-tumor immunity superior to checkpoint blockade alone

Mark Maurer,Chelsea Gudgeon,Katherine Lewis,Sherri Mudri,Stacey Dillon,Martin Wolfson,Steven Levin,Kristine Swiderek,Stanford Peng

JOURNAL FOR IMMUNOTHERAPY OF CANCER（2019）

引用0浏览0引用

Abstract 4550: CD80 Vigd-Fc Proteins Combine Checkpoint Antagonism and Costimulatory Signaling for Potent Antitumor Immunity

Ryan Swanson,Mark F. Maurer,Chris L. Navas,Chelsea J. Gudgeon,Joseph L. Kuijper,Martin Wolfson,Katherine E. Lewis,Stacey R. Dillon, Steve D. Levin,Michael G. Kornacker

Cancer research（2018）

引用0浏览0引用

PD-1 Blockade Enhances Elotuzumab Efficacy in Mouse Tumor Models

N. Bezman,A. Jhatakia,A. Kearney,T. Brender,M. Maurer,C. Sum, M. Lei,K. Waggie, J. Postelnek, K. Henning,M. Jenkins, A. Rogers,P. Neeson,A. Korman,M. Robbins,R. Graziano

Blood Advancesno. 12 (2017): 753-765

引用38浏览0WOS引用

Novel immuno-oncology biologics derived via directed evolution of IgSF domains

Mark Maurer,Ryan Swanson,Michael Kornacker,Steve Levin,Chris Navas,Chelsea Gudgeon,Lawrence Evans,Martin Wolfson,Dan Ardourel,Daniel DeMonte,Joseph Kuijper,Sean MacNeil,Janhavi Bhandari,Mark Rixon,Stanford Peng

JOURNAL FOR IMMUNOTHERAPY OF CANCER（2017）

引用0浏览0引用

Targeting multiple inhibitory receptors in melanoma

Joe-Marc Chauvin,Ornella Pagliano,Julien Fourcade,Zhaojun Sun,Hong Wang,Cindy Sanders,John M. Kirkwood,Tseng-Hui Timothy Chen,Mark Maurer,Alan J. Korman,Hassane M. Zarour

JOURNAL OF TRANSLATIONAL MEDICINE（2016）

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn